- Publish Date: Posted etwa 1 Jahr her
- Author: Nick Mahoney
Ep 7 | Building an AI platform to tackle complex diseases
In the final episode of series 2, Nick is joined by Dr. Muhunthan Thillai, the co-founder and CEO of Qureight and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company.
Dr. Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension.
To speak to Nick, please drop an email to firstname.lastname@example.org
Apple > https://apple.co/3qvIgN2
Spotify > https://spoti.fi/3qvwQsW
Anchor > https://anchor.fm/scipro